Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Med Chem ; 55(14): 6352-62, 2012 Jul 26.
Article in English | MEDLINE | ID: mdl-22734622

ABSTRACT

3-Iodobenzoylnaltrexamide 1 (IBNtxA) is a potent analgesic acting through a novel receptor target that lack many side-effects of traditional opiates composed, in part, of exon 11-associated truncated six transmembrane domain MOR-1 (6TM/E11) splice variants. To better understand the SAR of this drug target, a number of 4,5-epoxymorphinan analogues were synthesized. Results show the importance of a free 3-phenolic group, a phenyl ring at the 6 position, an iodine at the 3'or 4' position of the phenyl ring, and an N-allyl or c-propylmethyl group to maintain high 6TM/E11 affinity and activity. 3-Iodobenzoylnaloxamide 15 (IBNalA) with a N-allyl group displayed lower δ opioid receptor affinity than its naltrexamine analogue, was 10-fold more potent an analgesic than morphine, elicited no respiratory depression or physical dependence, and only limited inhibition of gastrointestinal transit. Thus, the aryl-naloxamide scaffold can generate a potent analgesic acting through the 6TM/E11 sites with advantageous side-effect profile and greater selectivity.


Subject(s)
Amides/chemical synthesis , Amides/pharmacology , Exons/genetics , Opiate Alkaloids/chemical synthesis , Opiate Alkaloids/pharmacology , Receptors, Opioid, mu/genetics , Receptors, Opioid, mu/metabolism , Amides/chemistry , Amides/metabolism , Analgesics/chemical synthesis , Analgesics/chemistry , Analgesics/metabolism , Analgesics/pharmacology , Animals , Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Cell Line , Chemistry Techniques, Synthetic , Male , Mice , Opiate Alkaloids/chemistry , Opiate Alkaloids/metabolism , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary , Receptors, Opioid, mu/chemistry , Structure-Activity Relationship
2.
Proc Natl Acad Sci U S A ; 108(49): 19778-83, 2011 Dec 06.
Article in English | MEDLINE | ID: mdl-22106286

ABSTRACT

Pain remains a pervasive problem throughout medicine, transcending all specialty boundaries. Despite the extraordinary insights into pain and its mechanisms over the past few decades, few advances have been made with analgesics. Most pain remains treated by opiates, which have significant side effects that limit their utility. We now describe a potent opiate analgesic lacking the traditional side effects associated with classical opiates, including respiratory depression, significant constipation, physical dependence, and, perhaps most important, reinforcing behavior, demonstrating that it is possible to dissociate side effects from analgesia. Evidence indicates that this agent acts through a truncated, six-transmembrane variant of the G protein-coupled mu opioid receptor MOR-1. Although truncated splice variants have been reported for a number of G protein-coupled receptors, their functional relevance has been unclear. Our evidence now suggests that truncated variants can be physiologically important through heterodimerization, even when inactive alone, and can comprise new therapeutic targets, as illustrated by our unique opioid analgesics with a vastly improved pharmacological profile.


Subject(s)
Alternative Splicing , Analgesics, Opioid/pharmacology , Naltrexone/analogs & derivatives , Naltrexone/pharmacology , Pain/prevention & control , Receptors, Opioid, mu/genetics , Analgesics, Opioid/chemistry , Analgesics, Opioid/metabolism , Animals , Binding, Competitive , Dose-Response Relationship, Drug , Gastrointestinal Motility/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Structure , Naltrexone/chemistry , Naltrexone/metabolism , Pain Measurement/methods , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Multimerization , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Receptors, Opioid, mu/chemistry , Receptors, Opioid, mu/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...